Cytiva and Longitude (a Financial Times company) reveal five major challenges for the industry in new Global Biopharma Resilience Index Kumar Jeetendra | March 8, 2021 Global life sciences leader Cytiva, along with the Financial Times’ research arm Longitude, have compiled a global index, ranking the ability of the biopharma industry to respond to five major challenges; in supply chain, talent, research and development, manufacturing, and government policy and regulation. Respondents answered questions on a scale of 1 to 10 in …
